142 related articles for article (PubMed ID: 37147555)
1. Severe skin ulcer caused by taking lenvatinib after proton beam therapy.
Iwasa T; Adachi S; Ogiso H; Takada E; Mabuchi M; Suzuki Y; Yamauchi O; Saito K; Iwashita T; Ogino H; Shimizu M
Clin J Gastroenterol; 2023 Aug; 16(4):588-592. PubMed ID: 37147555
[TBL] [Abstract][Full Text] [Related]
2. Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.
Cheng JY; Huang BS; Chen YY; Wang CC; Chen YH
Anticancer Res; 2023 Mar; 43(3):1361-1371. PubMed ID: 36854503
[TBL] [Abstract][Full Text] [Related]
3. An unexpected skin ulcer and soft tissue necrosis after the nonconcurrent combination of proton beam therapy and pazopanib: A case of myxofibrosarcoma.
Uwa N; Terada T; Mohri T; Tsukamoto Y; Futani H; Demizu Y; Okimoto T; Sakagami M
Auris Nasus Larynx; 2017 Aug; 44(4):484-488. PubMed ID: 27523716
[TBL] [Abstract][Full Text] [Related]
4. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
5. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
6. Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
Suoh M; Hagihara A; Yamamura M; Maruyama H; Taira K; Enomoto M; Tamori A; Fujiwara Y; Kawada N
Intern Med; 2021 Feb; 60(4):545-552. PubMed ID: 33028766
[TBL] [Abstract][Full Text] [Related]
7. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
Yoo GS; Yu JI; Park HC
World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
[TBL] [Abstract][Full Text] [Related]
9. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
[TBL] [Abstract][Full Text] [Related]
10. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.
Takahashi H; Sekino Y; Mori K; Okumura T; Nasu K; Fukuda K; Masuoka S; Iizumi T; Hasegawa N; Sakurai H; Minami M
Br J Radiol; 2020 Jan; 93(1105):20190375. PubMed ID: 31670572
[TBL] [Abstract][Full Text] [Related]
11. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
12. Proton Beam Therapy in Liver Malignancies.
Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
15. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma.
Mizumoto M; Okumura T; Hashimoto T; Fukuda K; Oshiro Y; Fukumitsu N; Abei M; Kawaguchi A; Hayashi Y; Ohkawa A; Hashii H; Kanemoto A; Moritake T; Tohno E; Tsuboi K; Sakae T; Sakurai H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e529-35. PubMed ID: 22284041
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma.
Ikeda A; Aoki K; Kawamura M; Yamaguchi D; Kokuryu H
Intern Med; 2021; 60(3):403-407. PubMed ID: 33518611
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
[TBL] [Abstract][Full Text] [Related]
20. Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Nosaka T; Matsuda H; Sugata R; Akazawa Y; Takahashi K; Naito T; Ohtani M; Kinoshita K; Tsujikawa T; Sato Y; Maeda Y; Tamamura H; Nakamoto Y
Curr Oncol; 2023 Mar; 30(4):3915-3926. PubMed ID: 37185409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
